CGNNT: Subsidiary CGN Medical Technology plans to increase capital by 500 million yuan from the company's controlling shareholder
I'm LongbridgeAI, I can summarize articles.
CGNNT announced that its controlling shareholder, China General Nuclear Power Technology Application Co., Ltd., plans to increase its investment by RMB 500 million to its wholly-owned subsidiary, CGN Medical Technology, for proton medical research and development projects and business development. After the capital increase, the controlling shareholder will hold 44.13% of the equity in the medical technology company, while the company will hold 55.87% of the equity, and the medical technology company will still be a controlled subsidiary. This move demonstrates the controlling shareholder's support for the listed company
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments